Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
3
×
wisconsin blog main
wisconsin top stories
zolgensma
abbvie
amgen
avexis
biogen
brian kaspar
bristol-myers squibb
cancer immunotherapy
centers for disease control and prevention
eli lilly
What
news
3
×
roundup
3
×
bio
biotech
nash
according
akcea
approval
august
biogen’s
biopharmaceutical
busy
cases
centers
cigarettes
companies
control
convo
days
deaths
decisions
devices
disease
drug
drugs
earlier
electronic
failures
fda
including
injuries
legacy
linked
littered
lung
new
nods
opioid
past
prevention
Language
unset
Current search:
roundup
×
novartis
×
" texas top stories "
×
news
×
" boston top stories "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More